Richmond Pharmacology is a full-service clinical research organisation based in London, UK. Founded in 2001, Richmond Pharmacology is led by its founding directors Dr Jorg Taubel, CEO and Dr Ulrike Lorch, whose experience has been gained in more than 500 clinical trials. Specialist services: * Early phase adaptive studies including First-In-Human * Cardiac Safety/Intensive ECG/Thorough QT studies * Ethnic Bridging studies * Early phase patient studies (therapeutic and non-therapeutic). Full service: * Consultancy and Expert Advice * Protocol Writing & CRF Design * Regulatory and Ethics Committee Applications * Healthy Volunteer/Patient Recruitment for Phase I-IV * Clinical Conduct, Pharmacy services * Safety Laboratory and Bioanalytical services * Data Management & Statistics and Report Writing linktr.ee/richmondpharmacology